# Skills

## Technical Skills — Current

| Skill | Proficiency | Years | Last Used |
|-------|------------|-------|-----------|
| AI/ML Strategy | Advanced | 5 | 2026-02 |
| Project Portfolio Management | Expert | 8 | 2026-02 |
| Cross-Functional Facilitation | Expert | 7 | 2026-02 |
| Stakeholder Communication | Expert | 8 | 2026-02 |
| Drug Discovery Workflow | Intermediate | 4 | 2026-02 |
| Data Governance & Compliance | Intermediate | 3 | 2026-01 |
| AI Business Case & ROI Modeling | Intermediate | 2 | 2026-02 |

## Skills to Develop — Tier 1 (Critical, next 3 months)

| Skill | Current | Target | Why Durable |
|-------|---------|--------|-------------|
| Prompt Engineering & LLM APIs | Foundational | Intermediate | Foundation for every prototype; builds intuition for what's feasible |
| Agentic AI Frameworks (LangGraph/CrewAI) | Foundational | Intermediate | Top project interest; must demo credibly to earn investment |
| AI Business Case Architecture | Intermediate | Advanced | Converts prototypes to funded programs; stakeholder buy-in weapon |
| Healthcare AI Governance (NIST AI RMF, FDA) | Foundational | Intermediate | Regulatory judgment can't be automated; be the "can we do this?" person |

## Skills to Develop — Tier 2 (Strategic, months 3-9)

| Skill | Current | Target | Why Durable |
|-------|---------|--------|-------------|
| Organizational Change Management | Foundational | Intermediate | When everyone can prototype, the bottleneck is adoption |
| Cross-Domain Pattern Recognition | Intermediate | Advanced | Translating what works in fintech/retail to pharma = unique value |
| Enterprise Data Strategy | Foundational | Intermediate | Models commoditize, data doesn't; know where the enterprise gold is |
| Vendor Evaluation & Build/Buy/Partner | Foundational | Intermediate | Enterprises buy more AI than they build; deciding when = massive leverage |
| RAG Architecture Patterns | Foundational | Intermediate | Decision support systems need retrieval; core project interest |

## Skills to Develop — Tier 3 (Executive trajectory, months 9-18)

| Skill | Current | Target | Why Durable |
|-------|---------|--------|-------------|
| Board-Level AI Communication | None | Foundational | Translate AI implications into business risk/opportunity for non-technical leaders |
| AI Portfolio Management | Foundational | Intermediate | Manage a portfolio of AI bets like a VC — fund/kill/pivot on evidence |
| Enterprise Architecture Thinking | Foundational | Intermediate | How AI reshapes the entire operating model, not just individual solutions |
| Industry Thought Leadership | None | Foundational | Publishing, speaking, external reputation — creates gravity and compounds |

## Domain Skills

| Skill | Proficiency | Years | Last Used |
|-------|------------|-------|-----------|
| Pharmaceutical R&D Landscape | Advanced | 6 | 2026-02 |
| Regulatory Awareness (FDA/EMA) | Intermediate | 4 | 2026-01 |
| Clinical Trial Design (Concepts) | Foundational | 2 | 2025-12 |
| Healthcare Data Standards (FHIR/HL7) | Foundational | 0 | — |

## Soft Skills
- Translating between R&D scientists (biology language) and data scientists (ML language)
- Seeing across domains to spot where AI solves real workflow pain points
- Building cross-functional buy-in that gets projects from idea to pilot
- Constraint-first evaluation — mapping blockers before investing effort
- Executive storytelling — 3-minute pitch for every prototype, speaking in outcomes not technology
- Trust-based influence — building the sponsor relationships that convert ideas into investments
